RT Book, Section
A1 Pacak, Karel
A1 Fojo, Tito
A2 Boyiadzis, Michael M.
A2 Fojo, Tito
SR Print(0)
ID 1187884463
T1 Pheochromocytoma
T2 Hematology-Oncology Therapy, 3e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781260117400
LK hemonc.mhmedical.com/content.aspx?aid=1187884463
RD 2024/04/23
AB EpidemiologyTable  Graphic  Jump  Location|Download  (.pdf)|PrintEpidemiologyIncidence✫:3–8  cases  per  one  million  populationMedian  age:42  yearsMale  to  female  ratio:1:1✫The  annual  incidence  of  pheochromocytoma  in  the  United  States  is  not  precisely  known,  but  the  high  prevalence  (0.05%)  of  pheochromocytomas  found  in  autopsy  series  indicates  that  the  tumor  is  underdiagnosed  and  that  the  annual  incidence  is  likely  to  be  higher  than  indicated  Beard  CM  et  al.  Mayo  Clin  Proc  1983;58:802–804Eisenhofer  G  et  al.  Endocr  Relat  Cancer  2004;11:423–436Neumann  HPH  et  al.  N  Engl  J  Med  2002;346:1459–1466Pacak  K  et  al.  Nat  Clin  Pract  Endocrinol  Metab  2007;3:91–102Stenstrom  et  al.  Acta  Med  Scand  1986;220:225–232